Related references
Note: Only part of the references are listed.Risk Factors for Kaposi's Sarcoma-Associated Herpesvirus DNA in Blood and in Saliva in Rural Uganda
Angela Nalwoga et al.
CLINICAL INFECTIOUS DISEASES (2020)
KSHV: Immune Modulation and Immunotherapy
Grant Broussard et al.
FRONTIERS IN IMMUNOLOGY (2020)
Human leukocyte antigen (HLA) diversity and clinical applications in South Africa
J. Mellet et al.
SAMJ SOUTH AFRICAN MEDICAL JOURNAL (2019)
Kaposi Sarcoma-Associated Herpesvirus in a Rural Ugandan Cohort, 1992-2008
Robert Newton et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
Determinants of Gammaherpesvirus Shedding in Saliva Among Ugandan Children and Their Mothers
Robert Newton et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
T-cell responses to KSHV infection: a systematic approach
Romin Roshan et al.
ONCOTARGET (2017)
HIV-associated Kaposi sarcoma and related diseases
Priscila H. Goncalves et al.
AIDS (2017)
Heterogeneity of HIV incidence: a comparative analysis between fishing communities and in a neighbouring rural general population, Uganda, and implications for HIV control
A. Kamali et al.
SEXUALLY TRANSMITTED INFECTIONS (2016)
Association between malaria exposure and Kaposi's sarcoma-associated herpes virus seropositivity in Uganda
Angela Nalwoga et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2015)
Trends in Kaposi's sarcoma-associated Herpesvirus antibodies prior to the development of HIV-associated Kaposi's sarcoma: A nested case-control study
Katie Wakeham et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Heterogeneity and Breadth of Host Antibody Response to KSHV Infection Demonstrated by Systematic Analysis of the KSHV Proteome
Nazzarena Labo et al.
PLOS PATHOGENS (2014)
The general population cohort in rural south-western Uganda: a platform for communicable and non-communicable disease studies
Gershim Asiki et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2013)
T-cell immunity to human alphaherpesviruses
Werner J. D. Ouwendijk et al.
CURRENT OPINION IN VIROLOGY (2013)
T-cell immunity to Kaposi sarcoma-associated herpesvirus: recognition of primary effusion lymphoma by LANA-specific CD4+ T cells
Shereen Sabbah et al.
BLOOD (2012)
Infectious agents in human cancers: Lessons in immunity and immunomodulation from gammaherpesviruses EBV and KSHV
Graham S. Taylor et al.
CANCER LETTERS (2011)
Differences in Kaposi sarcoma-associated herpesvirus-specific and herpesvirus-non-specific immune responses in classic Kaposi sarcoma cases and matched controls in Sicily
Emanuele Amodio et al.
CANCER SCIENCE (2011)
Active lytic infection of human primary tonsillar B cells by KSHV and its noncytolytic control by activated CD4+ T cells
Jinjong Myoung et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Cellular immune responses and disease control in acute AIDS-associated Kaposi's sarcoma
Florian Bihl et al.
AIDS (2009)
Changes in T-Cell Responses Against Human Herpesvirus-8 Correlate with the Disease Course of Iatrogenic Kaposi's Sarcoma in a Patient with Undifferentiated Arthritis
Patrizia Barozzi et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2009)
Human herpesvirus 8 load and progression of AIDS-related Kaposi sarcoma lesions
Martin M. Nsubuga et al.
CANCER LETTERS (2008)
CD8+T cell immunity to Epstein-Barr virus and Kaposi's sarcoma-associated herpes virus
Andrew D. Hislop et al.
SEMINARS IN CANCER BIOLOGY (2008)
Changes in the immune responses against human herpesvirus-8 in the disease course of posttransplant Kaposi sarcoma
Patrizia Barozzi et al.
TRANSPLANTATION (2008)
HIV-associated Kaposi's sarcoma with a high CD4 count and a low viral load
Toby Maurer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Human herpesvirus 8 presence and viral load are associated with the progression of AIDS-associated Kaposi's sarcoma
A. Scott Laney et al.
AIDS (2007)
Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma
Florian Bihl et al.
AIDS (2007)
Differences in the frequency and function of HHV8-specific CD8 T cells between asymptomatic HHV8 infection and Kaposi sarcoma
Marion Lambert et al.
BLOOD (2006)
Low T cell responses to human herpesvirus 8 in patients with AIDS-related and classic Kaposi sarcoma
Amelie Guihot et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Impact of Kaposi sarcoma-associated herpesvirus (KSHV) burden and HIV coinfection on the detection of T cell responses to KSHVORF73 and ORF65 proteins
T Woodberry et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Short- and long-term effects of highly active antiretroviral therapy on Kaposi sarcoma-associated herpesvirus immune responses and viraemia
D Bourboulia et al.
AIDS (2004)
Mother-to-child transmission of human herpesvirus-8 in South Africa
M Dedicoat et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Detection and quantification of Kaposi's sarcoma-associated herpesvirus to predict AIDS-associated Kaposi's sarcoma
EA Engels et al.
AIDS (2003)
Prognostic value of quantitative Kaposi sarcoma-associated herpesvirus load in posttransplantation Kaposi sarcoma
C Pellet et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Identification of cytotoxic T lymphocyte epitopes of human herpesvirus 8
F Micheletti et al.
IMMUNOLOGY (2002)
Prevalence of Kaposi's sarcoma-associated herpesvirus infection in sex workers and women from the general population in Spain
S De Sanjose et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Viral load of human herpesvirus 8 in peripheral blood of human immunodeficiency virus-infected patients with Kaposi's sarcoma
R Tedeschi et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2001)
Kaposi's sarcoma-associated herpesvirus latent and lytic gene expression as revealed by DNA arrays
RG Jenner et al.
JOURNAL OF VIROLOGY (2001)
Impaired CTL recognition of cells latently infected with Kaposi's sarcoma-associated herpes virus
C Brander et al.
JOURNAL OF IMMUNOLOGY (2000)
CD8(+) cytotoxic T lymphocyte responses to lytic proteins of human herpes virus 8 in human immunodeficiency virus type 1-infected and -uninfected individuals
QJ Wang et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Share Paper
